Status:
COMPLETED
N-Acetylcysteine for Pediatric Trichotillomania
Lead Sponsor:
Yale University
Collaborating Sponsors:
Trichotillomania Learning Center
Conditions:
Trichotillomania
Hair Pulling
Eligibility:
All Genders
8-17 years
Phase:
PHASE2
Brief Summary
Trichotillomania (hair pulling) has an estimated lifetime prevalence of 1-3%. Children with trichotillomania can experience significant impairment due to peer teasing, avoidance of activities (such as...
Eligibility Criteria
Inclusion
- Children aged 8-17 years.
- Primary DSM-IV diagnosis of trichotillomania or chronic hair pulling.
- Duration of trichotillomania greater than 6 months.
Exclusion
- Comorbid bipolar disorder, psychotic disorder, substance use disorder, developmental disorder or mental retardation (IQ\<70).
- Recent change (less than 4 weeks) in medications that have potential effects on TTM severity (such as SSRIs, CMI, naltrexone, lithium, psychostimulants, anxiolytics, or antipsychotics). Medication change is defined to include either dose changes or medication discontinuation.
- Asthma requiring medication use within the last 6 months.
- Known hypersensitivity or previous anaphylactoid reaction to acetylcysteine or any components in its preparation
- Current use (within last week) of psychostimulant medications.
- Positive pregnancy test or drug screening test
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00993265
Start Date
October 1 2009
End Date
March 1 2014
Last Update
July 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Child Study Center
New Haven, Connecticut, United States, 06520